Beck Veronica C, Hull Jacob M, Isom Lori L
Epilepsy Curr. 2019 Jul-Aug;19(4):266-268. doi: 10.1177/1535759719858339. Epub 2019 Jun 30.
Sadleir LG, Mountier EI, Gill D, et al. . 2017;89(10):1035-1042.
To define a distinct developmental and epileptic encephalopathy with early onset, profound impairment, and movement disorder.
A case series of 9 children were identified with a profound developmental and epileptic encephalopathy and mutation.
We identified 9 children 3 to 12 years of age; 7 were male. Seizure onset was at 6 to 12 weeks with hemiclonic seizures, bilateral tonic-clonic seizures, or spasms. All children had profound developmental impairment and were nonverbal and nonambulatory, and 7 of 9 required a gastrostomy. A hyperkinetic movement disorder occurred in all and was characterized by dystonia and choreoathetosis with prominent oral dyskinesia and onset from 2 to 20 months of age. Eight had a recurrent missense mutation, p.Thr226Met. The remaining child had the missense mutation p.Pro1345Ser. The mutation arose de novo in 8 of 9; for the remaining case, the mother was negative and the father was unavailable.
Here, we present a phenotype-genotype correlation for . We describe a distinct phenotype, early infantile encephalopathy, which is readily distinguishable from the well-recognized entities of Dravet syndrome and genetic epilepsy with febrile seizures plus. This disorder has an earlier age at onset, profound developmental impairment, and a distinctive hyperkinetic movement disorder, setting it apart from Dravet syndrome. Remarkably, 8 of 9 children had the recurrent missense mutation p.Thr226Met. Berecki G, Bryson A, Terhag J, et al. . 2019; 85:514-525.
To elucidate the biophysical basis underlying the distinct and severe clinical presentation in patients with the recurrent missense SCN1A variant, p.Thr226Met. Patients with this variant show a well-defined genotype-phenotype correlation and present with developmental and early infantile epileptic encephalopathy that is far more severe than typical SCN1A Dravet syndrome.
Whole cell patch clamp and dynamic action potential clamp were used to study T226M Nav 1.1 channels expressed in mammalian cells. Computational modeling was used to explore the neuronal scale mechanisms that account for altered action potential firing.
T226M channels exhibited hyperpolarizing shifts of the activation and inactivation curves and enhanced fast inactivation. Dynamic action potential clamp hybrid simulation showed that model neurons containing T226M conductance displayed a left shift in rheobase relative to control. At current stimulation levels that produced repetitive action potential firing in control model neurons, depolarization block and cessation of action potential firing occurred in T226M model neurons. Fully computationally simulated neuron models recapitulated the findings from dynamic action potential clamp and showed that heterozygous T226M models were also more susceptible to depolarization block.
From a biophysical perspective, the T226M mutation produces gain of function. Somewhat paradoxically, our data suggest that this gain of function would cause interneurons to more readily develop depolarization block. This "functional dominant negative" interaction would produce a more profound disinhibition than seen with haploinsufficiency that is typical of Dravet syndrome and could readily explain the more severe phenotype of patients with T226M mutation.
萨德勒 LG、芒蒂尔 EI、吉尔 D 等。. 2017 年;89(10):1035 - 1042。
定义一种具有早发性、严重损害和运动障碍的独特发育性和癫痫性脑病。
确定了 9 例患有严重发育性和癫痫性脑病及突变的儿童病例系列。
我们确定了 9 名 3 至 12 岁的儿童;7 名男性。癫痫发作始于 6 至 12 周,表现为半侧阵挛性发作、双侧强直阵挛性发作或痉挛。所有儿童均有严重发育障碍,不会说话且不能行走,9 名中有 7 名需要胃造口术。所有儿童均出现运动增多性运动障碍,其特征为肌张力障碍和舞蹈手足徐动症,伴有明显的口部运动障碍,发病年龄为 2 至 20 个月。8 名儿童有复发性错义突变 p.Thr226Met。其余 1 名儿童有错义突变 p.Pro1345Ser。9 名中有 8 名的突变是新发的;对于其余 1 例,母亲检测为阴性,父亲无法联系到。
在此,我们展示了……的表型 - 基因型相关性。我们描述了一种独特的表型,即早发性婴儿脑病,它很容易与公认的德雷维特综合征和伴有热性惊厥附加症的遗传性癫痫区分开来。这种疾病起病年龄更早,有严重发育障碍,且有独特的运动增多性运动障碍,与德雷维特综合征不同。值得注意的是,9 名儿童中有 8 名有复发性错义突变 p.Thr226Met。
贝雷茨基 G、布赖森 A、特尔哈格 J 等。. 2019 年;85:514 - 525。
阐明复发性错义 SCN1A 变体 p.Thr226Met 患者独特且严重临床表现背后的生物物理基础。具有这种变体的患者表现出明确的基因型 - 表型相关性,并患有发育性和早发性癫痫性脑病,远比典型的 SCN1A 德雷维特综合征严重。
采用全细胞膜片钳和动态动作电位钳技术研究在哺乳动物细胞中表达 的 T226M Nav 1.1 通道。使用计算建模来探索解释动作电位发放改变的神经元尺度机制。
T226M 通道表现出激活和失活曲线的超极化偏移以及增强快速失活。动态动作电位钳混合模拟显示含有 T226M 电导的模型神经元相对于对照在阈强度电流上有向左偏移。在对照模型神经元中产生重复动作电位发放的电流刺激水平下,T226M 模型神经元出现去极化阻滞和动作电位发放停止。完全通过计算模拟的神经元模型概括了动态动作电位钳的结果,并表明杂合 T226M 模型也更容易出现去极化阻滞。
从生物物理角度来看,T226M 突变产生功能增益。有点矛盾的是,我们的数据表明这种功能增益会导致中间神经元更容易出现去极化阻滞。这种“功能性显性负性”相互作用会产生比德雷维特综合征典型的单倍体不足更严重的去抑制作用,并且可以很容易地解释 T226M 突变患者更严重的表型。